267 related articles for article (PubMed ID: 28389129)
1. Sirtuin Inhibition: Strategies, Inhibitors, and Therapeutic Potential.
Jiang Y; Liu J; Chen D; Yan L; Zheng W
Trends Pharmacol Sci; 2017 May; 38(5):459-472. PubMed ID: 28389129
[TBL] [Abstract][Full Text] [Related]
2. The chemical biology of sirtuins.
Chen B; Zang W; Wang J; Huang Y; He Y; Yan L; Liu J; Zheng W
Chem Soc Rev; 2015 Aug; 44(15):5246-64. PubMed ID: 25955411
[TBL] [Abstract][Full Text] [Related]
3. Chemical Probes in Sirtuin Research.
Hu X; Zheng W
Prog Mol Biol Transl Sci; 2018; 154():1-24. PubMed ID: 29413174
[TBL] [Abstract][Full Text] [Related]
4. Sirtuins inhibitors: the approach to affinity and selectivity.
Cen Y
Biochim Biophys Acta; 2010 Aug; 1804(8):1635-44. PubMed ID: 19931429
[TBL] [Abstract][Full Text] [Related]
5. An overview of Sirtuins as potential therapeutic target: Structure, function and modulators.
Wang Y; He J; Liao M; Hu M; Li W; Ouyang H; Wang X; Ye T; Zhang Y; Ouyang L
Eur J Med Chem; 2019 Jan; 161():48-77. PubMed ID: 30342425
[TBL] [Abstract][Full Text] [Related]
6. Review: The plant sirtuins.
Zheng W
Plant Sci; 2020 Apr; 293():110434. PubMed ID: 32081272
[TBL] [Abstract][Full Text] [Related]
7. Kinetic and Structural Basis for Acyl-Group Selectivity and NAD(+) Dependence in Sirtuin-Catalyzed Deacylation.
Feldman JL; Dittenhafer-Reed KE; Kudo N; Thelen JN; Ito A; Yoshida M; Denu JM
Biochemistry; 2015 May; 54(19):3037-3050. PubMed ID: 25897714
[TBL] [Abstract][Full Text] [Related]
8. The mimics of N
Wang C; Wang F; Chen X; Zou Y; Zhu H; Zhao Q; Shen J; Li Y; Li Y; He B
Bioorg Med Chem Lett; 2018 Aug; 28(14):2375-2378. PubMed ID: 29921476
[TBL] [Abstract][Full Text] [Related]
9. Sirtuin mechanism and inhibition: explored with N(ε)-acetyl-lysine analogs.
Hirsch BM; Zheng W
Mol Biosyst; 2011 Jan; 7(1):16-28. PubMed ID: 20842312
[TBL] [Abstract][Full Text] [Related]
10. Structure-activity studies on suramin analogues as inhibitors of NAD+-dependent histone deacetylases (sirtuins).
Trapp J; Meier R; Hongwiset D; Kassack MU; Sippl W; Jung M
ChemMedChem; 2007 Oct; 2(10):1419-31. PubMed ID: 17628866
[TBL] [Abstract][Full Text] [Related]
11. Simple N(ε)-thioacetyl-lysine-containing cyclic peptides exhibiting highly potent sirtuin inhibition.
Huang Y; Liu J; Yan L; Zheng W
Bioorg Med Chem Lett; 2016 Mar; 26(6):1612-1617. PubMed ID: 26874402
[TBL] [Abstract][Full Text] [Related]
12. Structural basis of inhibition of the human NAD+-dependent deacetylase SIRT5 by suramin.
Schuetz A; Min J; Antoshenko T; Wang CL; Allali-Hassani A; Dong A; Loppnau P; Vedadi M; Bochkarev A; Sternglanz R; Plotnikov AN
Structure; 2007 Mar; 15(3):377-89. PubMed ID: 17355872
[TBL] [Abstract][Full Text] [Related]
13. A Selective Cyclic Peptidic Human SIRT5 Inhibitor.
Liu J; Huang Y; Zheng W
Molecules; 2016 Sep; 21(9):. PubMed ID: 27626398
[TBL] [Abstract][Full Text] [Related]
14. Oxadiazole-carbonylaminothioureas as SIRT1 and SIRT2 inhibitors.
Huhtiniemi T; Suuronen T; Rinne VM; Wittekindt C; Lahtela-Kakkonen M; Jarho E; Wallén EA; Salminen A; Poso A; Leppänen J
J Med Chem; 2008 Aug; 51(15):4377-80. PubMed ID: 18642893
[TBL] [Abstract][Full Text] [Related]
15. Mechanism-based modulator discovery for sirtuin-catalyzed deacetylation reaction.
Zheng W
Mini Rev Med Chem; 2013 Jan; 13(1):132-54. PubMed ID: 22876953
[TBL] [Abstract][Full Text] [Related]
16. Structure-based development of novel sirtuin inhibitors.
Schlicker C; Boanca G; Lakshminarasimhan M; Steegborn C
Aging (Albany NY); 2011 Sep; 3(9):852-72. PubMed ID: 21937767
[TBL] [Abstract][Full Text] [Related]
17. Sirt5 deacylation activities show differential sensitivities to nicotinamide inhibition.
Fischer F; Gertz M; Suenkel B; Lakshminarasimhan M; Schutkowski M; Steegborn C
PLoS One; 2012; 7(9):e45098. PubMed ID: 23028781
[TBL] [Abstract][Full Text] [Related]
18. Function and regulation of the mitochondrial sirtuin isoform Sirt5 in Mammalia.
Gertz M; Steegborn C
Biochim Biophys Acta; 2010 Aug; 1804(8):1658-65. PubMed ID: 19766741
[TBL] [Abstract][Full Text] [Related]
19. Sirtuins: multifaceted drug targets.
Chakrabarty SP; Balaram H; Chandrasekaran S
Curr Mol Med; 2011 Dec; 11(9):709-18. PubMed ID: 21999152
[TBL] [Abstract][Full Text] [Related]
20. Therapeutic potential of activators and inhibitors of sirtuins.
Balcerczyk A; Pirola L
Biofactors; 2010; 36(5):383-93. PubMed ID: 20848588
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
